Proschak E - Search Results

1

From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.

Buscató E, Büttner D, Brüggerhoff A, Klingler FM, Weber J, Scholz B, Zivković A, Marschalek R, Stark H, Steinhilber D, Bode HB, Proschak E. Buscató E, et al. Among authors: proschak e. ChemMedChem. 2013 Jun;8(6):919-23. doi: 10.1002/cmdc.201300057. Epub 2013 Apr 17. ChemMedChem. 2013. PMID: 23596124

2

Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase.

Hofmann B, Franke L, Proschak E, Tanrikulu Y, Schneider P, Steinhilber D, Schneider G. Hofmann B, et al. Among authors: proschak e. ChemMedChem. 2008 Oct;3(10):1535-8. doi: 10.1002/cmdc.200800153. ChemMedChem. 2008. PMID: 18688907 No abstract available.

3

PhAST: pharmacophore alignment search tool.

Hähnke V, Hofmann B, Grgat T, Proschak E, Steinhilber D, Schneider G. Hähnke V, et al. Among authors: proschak e. J Comput Chem. 2009 Apr 15;30(5):761-71. doi: 10.1002/jcc.21095. J Comput Chem. 2009. PMID: 18727161

4

From molecular shape to potent bioactive agents I: bioisosteric replacement of molecular fragments.

Proschak E, Zettl H, Tanrikulu Y, Weisel M, Kriegl JM, Rau O, Schubert-Zsilavecz M, Schneider G. Proschak E, et al. ChemMedChem. 2009 Jan;4(1):41-4. doi: 10.1002/cmdc.200800313. ChemMedChem. 2009. PMID: 19058279 No abstract available.

5

From molecular shape to potent bioactive agents II: fragment-based de novo design.

Proschak E, Sander K, Zettl H, Tanrikulu Y, Rau O, Schneider P, Schubert-Zsilavecz M, Stark H, Schneider G. Proschak E, et al. ChemMedChem. 2009 Jan;4(1):45-8. doi: 10.1002/cmdc.200800314. ChemMedChem. 2009. PMID: 19058280 No abstract available.

6

Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.

Tanrikulu Y, Proschak E, Werner T, Geppert T, Todoroff N, Klenner A, Kottke T, Sander K, Schneider E, Seifert R, Stark H, Clark T, Schneider G. Tanrikulu Y, et al. Among authors: proschak e. ChemMedChem. 2009 May;4(5):820-7. doi: 10.1002/cmdc.200800443. ChemMedChem. 2009. PMID: 19343764

7

Identification and validation of a potent type II inhibitor of inactive polo-like kinase 1.

Keppner S, Proschak E, Schneider G, Spänkuch B. Keppner S, et al. Among authors: proschak e. ChemMedChem. 2009 Nov;4(11):1806-9. doi: 10.1002/cmdc.200900338. ChemMedChem. 2009. PMID: 19746360 No abstract available.

8

2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.

Sander K, Kottke T, Tanrikulu Y, Proschak E, Weizel L, Schneider EH, Seifert R, Schneider G, Stark H. Sander K, et al. Among authors: proschak e. Bioorg Med Chem. 2009 Oct 15;17(20):7186-96. doi: 10.1016/j.bmc.2009.08.059. Epub 2009 Sep 2. Bioorg Med Chem. 2009. PMID: 19773175

9

Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.

Sander K, Kottke T, Proschak E, Tanrikulu Y, Schneider EH, Seifert R, Schneider G, Stark H. Sander K, et al. Among authors: proschak e. Inflamm Res. 2010 Mar;59 Suppl 2:S249-51. doi: 10.1007/s00011-009-0143-2. Inflamm Res. 2010. PMID: 20012148

10

From machine learning to natural product derivatives that selectively activate transcription factor PPARgamma.

Rupp M, Schroeter T, Steri R, Zettl H, Proschak E, Hansen K, Rau O, Schwarz O, Müller-Kuhrt L, Schubert-Zsilavecz M, Müller KR, Schneider G. Rupp M, et al. Among authors: proschak e. ChemMedChem. 2010 Feb 1;5(2):191-4. doi: 10.1002/cmdc.200900469. ChemMedChem. 2010. PMID: 20043315 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters